Boehringer Ingelheim Pharmaceuticals

900 Ridgebury Rd.
P.O. Box 368
Ridgefield
CT
06877
USA
Phone: 
800-243-0127
http://www.boehringer-ingelheim.com
Product Categories: Taxo=cardiac_rhythm_management_therapy&Taxo=ep_lab&Taxo=diagnostic_and_interventional_cardiology_daic&Taxo=pharmaceuticals

Related Articles

Atrial Fibrillation Therapies

Newly Approved Blood Thinner May Increase Viral Infections
Dabigatran Label Change Affirms Superior Reduction in Stroke Versus Warfarin

Pharmaceuticals

Newly Approved Blood Thinner May Increase Viral Infections
Dabigatran Label Change Affirms Superior Reduction in Stroke Versus Warfarin
New Publication Highlights Anticoagulant Therapy
FDA Approves Stroke Prevention Drug in Atrial Fibrillation Patients
FDA Committee Unanimously in Favor of Approving Stroke Prevention Drug

Antiplatelet Therapy

Newly Approved Blood Thinner May Increase Viral Infections
Dabigatran Label Change Affirms Superior Reduction in Stroke Versus Warfarin

Clinical Trial/Study

Dabigatran Label Change Affirms Superior Reduction in Stroke Versus Warfarin

Hypertension Therapies

FDA Approves Stroke Prevention Drug in Atrial Fibrillation Patients

Cardiac Rhythm Management Therapy

FDA Committee Unanimously in Favor of Approving Stroke Prevention Drug